Search Within

Hematology-Oncology Fellows

  1. "Nursing"
Formats
  1. Meeting Abstract (36)
  2. Journal Article (24)
  3. Research Letter (3)
  4. Editorial (1)
  5. Review (1)
Groups
  1. Department of Medicine (65)
  2. Nursing (65)
  3. Graduate Medical Education (43)
  4. GME, Medicine (42)
  5. Hematologic Malignancies, Division of (40)
  6. Center for Hematologic Malignancies (36)

More Groups

People
  1. Meghan Thompson (13)
  2. Andrew Zelenetz (12)
  3. Andriy Derkach (12)
  4. Ahmet Dogan (11)
  5. Lindsey Roeker (11)
  6. Anthony Mato (10)

More People

Years
  1. 2025 (2)
  2. 2024 (13)
  3. 2023 (13)
  4. 2022 (9)
  5. 2021 (19)
  6. 2020 (8)

More Years

Publications
  1. Blood (16)
  2. Journal of Clinical Oncology (15)
  3. Annals of Oncology (4)
  4. Clinical Cancer Research (4)
  5. Leukemia (2)
  6. The Lancet Haematology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (17)
  2. American Society of Hematology (17)
  3. American Association for Cancer Research (6)
  4. Oxford University Press (6)
  5. Nature Publishing Group (5)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (65)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Harmonization of the upfront osteosarcoma treatment paradigm for adolescents and young adults
    Journal Article

    Daukshus, N. P.; Avutu, V.; Long Sarro, E.; Kinnaman, M. D.; Slotkin, E. K.; Thornton, K.; Dickson, M. A.; Sklarin, N. T.; Tap, W. D.; Glade Bender, J.
    Journal of Adolescent and Young Adult Oncology (2025)

    Fulltext@MSK | Save
  • Prospective study of patient, nursing, and oncology provider perspectives on telemedicine visits for renal cell carcinoma clinical trials
    Journal Article

    Doshi, S. D.; Knezevic, A.; Gonzalez, C.; Fischer, P.; Goodman, R.; Gornell, S.; Patel, S.; Puzio, C.; Ritea, A.; Lee, C. H.; more...
    Clinical Genitourinary Cancer (2025)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Waiting to exhale: The feasibility and appropriateness of home blood oxygen monitoring in oncology patients post–hospital discharge
    Journal Article

    Liu, S. Y.; Doshi, S. D.; Ebstein, A. M.; Holland, J.; Sapir, A.; Leung, M.; Huang, J.; Fahy, R.; Salvaggio, R.; Begue, A.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma
    Meeting Abstract

    Gounder, M. M.; Rosen, E.; Parikh, A. R.; Conley, A. P.; Hong, D. S.; Sheth, S.; Mai, N.; Sgroe, E.; Mitchell, R.; Picard, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Therapeutic implications of acquired high tumor mutational burden (TMB-H) after targeted therapy (TT) in metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Yeh, C.; Harrold, E.; Keane, F.; Sinopoli, J. C.; Foote, M. B.; Cercek, A.; Yaeger, R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Osimertinib, platinum, etoposide as initial treatment for patients with EGFR mutant lung cancers with TP53 and RB1 alterations
    Meeting Abstract

    Chen, M. F.; Rakhade, S.; Quintanal-Villalonga, A.; Lee, J.; Forsythe, B.; Moses, K. A.; Ahn, L. S. H.; Pupo, A.; Falcon, C. J.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save